C. Ferran

S. Damrauer, C. Ferran, E. Csizmadia, 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

A20 inhibits NF-kappaB activation in endothelial cells without sensitizing to tumor necrosis factor-mediated apoptosis.

C. Ferran, S. Grey, F. Bach, 1998, Blood.

Overexpression of A1, an NF-κB–Inducible Anti-Apoptotic Bcl Gene, Inhibits Endothelial Cell Activation

C. Ferran, F. Bach, D. Stroka, 1999 .

Overexpression of A 1 , an NFk B – Inducible Anti-Apoptotic Bcl Gene , Inhibits Endothelial Cell Activation

C. Ferran, F. Bach, D. Stroka, 1999 .

Delivery of targeted gene therapies using a hybrid cryogel-coated prosthetic vascular graft

Ting-Yu Shih, F. Logerfo, D. Mooney, 2019, PeerJ.

Inhibition of NF-κB by Pyrrolidine Dithiocarbamate Blocks Endothelial Cell Activation

C. Ferran, F. Bach, C. Brostjan, 1995 .

Modification of vascular responses in xenotransplantation: Inflammation and apoptosis

C. Ferran, F. Bach, J. Anrather, 1997, Nature Medicine.

A20 Inhibits Cytokine-Induced Apoptosis and Nuclear Factor κB–Dependent Gene Activation in Islets

C. Ferran, S. Grey, W. Hasenkamp, 1999, The Journal of experimental medicine.

Carbon Monoxide Promotes Fas/CD95-induced Apoptosis in Jurkat Cells*

A. Choi, C. Ferran, L. Otterbein, 2004, Journal of Biological Chemistry.

A20 Modulates Lipid Metabolism and Energy Production to Promote Liver Regeneration

M. Bhasin, T. Libermann, S. Damrauer, 2011, PloS one.

Protective genes expressed in endothelial cells: a regulatory response to injury.

C. Ferran, F. Bach, W. Hancock, 1997, Immunology today.

Cytotoxicity associated with electrospun polyvinyl alcohol.

Tina M. Phaneuf, M. Phaneuf, M. Bide, 2015, Journal of biomedical materials research. Part B, Applied biomaterials.

Combined expression of A1 and A20 achieves optimal protection of renal proximal tubular epithelial cells.

C. Ferran, S. Grey, J. Floege, 2005, Kidney international.

A20 protects mice from lethal radical hepatectomy by promoting hepatocyte proliferation via a p21waf1‐dependent mechanism

C. Ferran, S. Grey, E. Csizmadia, 2005, Hepatology.

Pathogenesis of and potential therapies for delayed xenograft rejection

C. Ferran, F. Bach, J. Anrather, 1999 .

Adenovirus-mediated expression of a dominant negative mutant of p65/RelA inhibits proinflammatory gene expression in endothelial cells without sensitizing to apoptosis.

F. Steinhäuslin, C. Ferran, F. Bach, 1998, Journal of immunology.

Plasmid-mediated sucrose metabolism in Escherichia coli: characterization of scrY, the structural gene for a phosphoenolpyruvate-dependent sucrose phosphotransferase system outer membrane porin

C. Ferran, J. Dirienzo, C. Hardesty, 1991, Journal of bacteriology.

Expression of adhesion molecules in 113 patients with B-cell chronic lymphocytic leukemia: relationship with clinico-prognostic features.

E. González-Barca, A. Grañena, X. Castellsagué, 1997, Leukemia research.

Anti-tumor necrosis factor modulates anti-CD3-triggered T cell cytokine gene expression in vivo.

C. Ferran, L. Chatenoud, G. Grau, 1994, The Journal of clinical investigation.

TNFα-induced macrophage death via caspase-dependent and independent pathways

C. Ferran, L. Pagliari, Bo Shi, 2009, Apoptosis.

On the intraoperative molecular status of renal allografts after vascular reperfusion and clinical outcomes.

A. Monaco, W. Chon, C. Ferran, 2005, Journal of the American Society of Nephrology : JASN.

Xenotransplantation 1.0 to 2.0

C. Ferran, O. Haque, D. Cloonan, 2020, Transplantation Surgery.

Xenotransplantation: problems and approaches.

C. Ferran, F. Bach, W. Hancock, 1994, Transplantation Proceedings.

Xenotransplantation: endothelial cell activation and beyond.

C. Ferran, F. Bach, J. Anrather, 1995, Transplantation Proceedings.

The BH4 domain of A1, an anti-apoptotic bcl family gene, is necessary and sufficient for its antiinflammatory function in endothelial cells.

C. Ferran, D. Stroka, J. Mahiou, 2001, Transplantation proceedings.

Inhibition of NF-kappa B by pyrrolidine dithiocarbamate blocks endothelial cell activation.

C. Ferran, F. Bach, C. Brostjan, 1995, Biochemical and biophysical research communications.

A20/TNFAIP3 Increases ENOS Expression in an ERK5/KLF2-Dependent Manner to Support Endothelial Cell Health in the Face of Inflammation

C. Ferran, Herwig P. Moll, S. Daniel, 2021, Frontiers in Cardiovascular Medicine.

Translational studies of A20 in atherosclerosis and cardiovascular disease.

M. Reilly, S. Damrauer, C. Ferran, 2014, Advances in experimental medicine and biology.

Hepatocyte growth factor preferentially activates the anti‐inflammatory arm of NF‐κB signaling to induce A20 and protect renal proximal tubular epithelial cells from inflammation

S. Damrauer, C. Ferran, S. Daniel, 2012, Journal of cellular physiology.

A20 Haploinsufficiency Aggravates Transplant Arteriosclerosis in Mouse Vascular Allografts: Implications for Clinical Transplantation

C. Ferran, E. Csizmadia, A. Mele, 2016, Transplantation.

Anti-TNF abrogates the cytokine-related anti-CD3 induced syndrome.

C. Ferran, L. Chatenoud, J. Bach, 1991, Transplantation proceedings.

The graft unveils its secrets: provocative therapeutic leads to protected vascularized allografts.

C. Ferran, 2002, Transplant immunology.

Accommodation of xenografts: expression of "protective genes" in endothelial and smooth muscle cells.

D. Candinas, C. Ferran, F. Bach, 1997, Transplantation proceedings.

Overexpressin of A20 in endothelial cells of vascularized grafts creates a protective barrier against TNF- and FAS-mediated apoptosis

C. Ferran, S. Daniel, M. Arvelo, 2001 .

A20 and BCL proteins exert a broad and complementary cytoprotective effect in endothelial cells via blockade of NF-kappaB and NFAT.

C. Ferran, A. Badrichani, 2001, Transplantation proceedings.

Adenovirus-mediated gene transfer of A20 renders endothelial cells resistant to activation: a means of evaluating the role of endothelial cell activation in xenograft rejection.

C. Ferran, F. Bach, D. Stroka, 1997, Transplantation proceedings.

Fast Track On the Intraoperative Molecular Status of Renal Allografts after Vascular Reperfusion and Clinical Outcomes

A. Monaco, W. Chon, C. Ferran, 2005 .

Epstein-Barr virus infection is associated with endothelial Bcl-2 expression in transplant liver allografts.

Y. Natkunam, C. Ferran, C. Esquivel, 2002, Transplantation.

Forkhead Transcription Factors Inhibit Vascular Smooth Muscle Cell Proliferation and Neointimal Hyperplasia*[boxs]

W. Aird, C. Ferran, M. Abid, 2005, Journal of Biological Chemistry.

IN-VIVO ANTI-CD3 TREATMENT OF AUTOIMMUNE PATIENTS

C. Ferran, L. Chatenoud, J. Bach, 1989, The Lancet.

Embryonic periventricular endothelial cells demonstrate a unique pro-neurodevelopment and anti-inflammatory gene signature

Justin M. Moore, M. Bhasin, C. Ferran, 2020, Scientific Reports.

THE UNIVERSAL NF- κ B INHIBITOR A20 PROTECTS FROM TRANSPLANT VASCULOPATHY BY DIFFERENTIALLY AFFECTING APOPTOSIS IN EC AND SMC

C. Ferran, E. Csizmadia, S. Scali, 2006 .

[Acute clinical syndrome associated with OKT3 administration. Prevention by single injection of an anti-human TNF monoclonal antibody].

C. Ferran, L. Chatenoud, O. Lantz, 1991, Presse medicale.

Activation lymphocytaire T induite in vivo par la première injection de l'anticorps monoclonal OKT3

C. Ferran, L. Chatenoud, C. Legendre, 1988 .

Clinical applications of anti-T-cell monoclonal antibodies.

C. Ferran, L. Chatenoud, J. Bach, 1991, Advances in nephrology from the Necker Hospital.

Delayed xenograft rejection.

C. Ferran, F. Bach, S. Robson, 1996, World journal of surgery.

Expression of a negative dominant mutant of human p55 tumor necrosis factor-receptor inhibits TNF and monocyte-induced activation in porcine aortic endothelial cells.

C. Ferran, F. Bach, C. Brostjan, 1997, Transplantation proceedings.

O-glycosylation Regulates Ubiquitination and Degradation of the Anti-inflammatory Protein A20 to Accelerate Atherosclerosis in Diabetic Apoe-null Mice O-glycosylation Regulates Ubiquitination and Degradation of the Anti-inflammatory Protein A20 to Accelerate Atherosclerosis in Diabetic Apoe-null Mic

S. Damrauer, A. Veves, C. Ferran, 2022 .

A20-Mediated Modulation of Inflammatory and Immune Responses in Aortic Allografts and Development of Transplant Arteriosclerosis

S. Damrauer, C. Ferran, E. Csizmadia, 2012, Transplantation.

In vivo T cell activation properties of anti-T cell monoclonal antibodies.

C. Ferran, L. Chatenoud, J. Bach, 1993, Experimental nephrology.

A20, a modulator of smooth muscle cell proliferation and apoptosis, prevents and induces regression of neointimal hyperplasia

C. Ferran, S. Grey, S. Scali, 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.